By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
News for IndiaNews for IndiaNews for India
  • Home
  • Posts
  • Search Page
  • About us
Reading: Small-cap pharma stock hits 52-week high after fundraising move. Details here | Stock Market News
Share
Font ResizerAa
News for IndiaNews for India
Font ResizerAa
  • Economics
  • Business
  • Home
  • Categories
    • Business
    • Economics
  • About us
  • Sitemap
Follow US
  • Advertise
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
News for India > Business > Small-cap pharma stock hits 52-week high after fundraising move. Details here | Stock Market News
Business

Small-cap pharma stock hits 52-week high after fundraising move. Details here | Stock Market News

Last updated: June 16, 2026 11:27 am
2 months ago
Share
SHARE


Sudarshan Pharma Industries share price gained over 2% to hit a 52-week high on Tuesday after the company announced a fundraising proposal. The small-cap stock extended its gaining streak to seventh consecutive session and rose as much as 2.23% to a fresh high of ₹38.00 apiece on the BSE.

However, Sudarshan Pharma shares witnessed selling pressure at higher levels and succumbed to profit booking to trade lower.

Sudarshan Pharma Industries informed that the meeting of its Board of Directors is scheduled to be held on 18 June 2026, Thursday, to consider and approve a proposal for raising of funds.

The funds are proposed to be raised by way of issue of one or more of instruments comprising equity shares, convertible securities of any other description or warrants or debt securities, through Private Placement, Preferential Issue, Qualified Institutions Placement or such other methods or combinations thereof, Sudarshan Pharma said in a regulatory filing on June 15.

The board will also approve ancillary actions for the above mentioned fund raising, subject to such statutory and regulatory approvals as may be necessary, it added.

Earlier on June 12, the Warrants Committee of the company’s Board of Directors considered and approved the allotment of 90 lakh equity shares of face value of Re 1 each at an issue price of ₹16.983 each, consequent upon the conversion of 9 lakh Warrants issued at an Issue Price of ₹169.83 each, to the persons belonging to “Promoter Category”, on preferential basis.

These warrants were issued upon the receipt of balance amount aggregating to ₹11,46,35,250 at the rate of ₹127.37 per warrant (being 75% of the issue price per warrant) from the allottees pursuant to the exercise of their rights of conversion into equity shares.

Sudarshan Pharma Share Price Performance

Sudarshan Pharma share price has gained over 21% in one month and has jumped 56% in three months. The smallcap stock has rallied 47% in six months, and has advanced 24% in one year. Sudarshan Pharma shares have delivered multibagger returns of 400% in two years and 438% over the past three years.

At 11:25 AM, Sudarshan Pharma share price was trading 2.04% lower at ₹36.41 apiece on the BSE.



Source link

You Might Also Like

Cummins India faces margin, valuation hurdles despite robust demand | Stock Market News

Aegeus Technologies IPO allotment to be finalised today. Here’s GMP, how to check status online | Stock Market News

For LIC, successful OFS and strong Q1 may not provide succour yet | Stock Market News

Solar stock under ₹50 hits 52-week high after this Capex update. Do you own? | Stock Market News

Technocraft Ventures IPO Day 1 Live: GMP, subscription status, other details. Apply or not? | Stock Market News

TAGGED:multibagger smallcap stocksMultibagger Stockssmallcap multibagger stockssmallcap stock below rs 50smallcap stock under rs 50Smallcap stocksSudarshan Pharma IndustriesSudarshan Pharma share price
Share This Article
Facebook Twitter Email Print
Previous Article Access Denied
Next Article Access Denied

We influence 20 million users and is the number one business and technology news network on the planet.

Find Us on Socials

News for IndiaNews for India
© Wealth Wave Designed by Preet Patel. All Rights Reserved.
  • BUSINESS